Medical research

Newly identified receptor may help gene therapy go viral

Gene therapy, whereby a patient's disorder is treated by inserting a new gene, replacing a defective one, or disabling a harmful one, suffered a setback in 1999, when Jesse Gelsinger, an 18-year-old with a genetic liver disease, ...

Genetics

Is the first commercial gene therapy product within sight?

Highly anticipated phase III clinical trial results of Spark Therapeutics's gene therapy to treat visual impairment are due by year-end and could have profound implications for the broader gene therapy field, leading to the ...

Ophthalmology

Pioneering gene therapy takes aim at inherited blindness

Canada's first human gene therapy trial for eyes—the replacement of a faulty gene with a healthy one—is now underway at the Royal Alexandra Hospital to preserve and potentially restore vision for people with a genetic ...

Genetics

Genetically engineered athletes could be heading this way soon

A team from China grabbed the headlines last month when it announced it had edited DNA in the nucleus of human embryos. Whatever the ethics of such research, the breakthrough raises the question of just how far we will take ...

page 15 from 20